Introduction For the first time in nearly half a century, fatty liver disease has undergone a
change in name and definition, from the exclusive term, non-alcoholic fatty liver disease …

Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

We aimed to compare the associations of metabolic dysfunction-associated steatotic liver
disease (MASLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) with …

Background Variations in the prevalence and systemic inflammatory (SI) status between non-
alcoholic fatty liver disease (NAFLD) and newly defined metabolic dysfunction-associated …

Introduction Metabolic dysfunction–associated fatty liver disease (MAFLD) is newly
proposed nomenclature, and its diagnosis involves an algorithm that can be complicated …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is a recently
proposed term as a more appropriate definition for nonalcoholic fatty liver disease (NAFLD) …

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the
proposed name change for non-alcoholic fatty liver disease (NAFLD). This study aimed to …

Metabolic dysfunction-associated steatotic liver disease (MASLD) stands as an independent
risk factor for cardiovascular disease (CVD), which is the leading cause of mortality among …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a recently introduced
term for steatotic liver disease (SLD). Although the inflammatory process is central to the …

The prevalence of cardiovascular diseases (CVDs) is a growing global health concern.
Recent advances have demonstrated significant reductions in acute cardiovascular events …